MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Accelerate Diagnostics Betriebsaufwand 2011-2026 | AXDX
Betriebsaufwand Jährlich Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 77.2 M | 82.9 M | 67.4 M | 66.7 M | 45.7 M | 31.6 M | 15.3 M | 3.59 M | 1.53 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 82.9 M | 1.53 M | 43.6 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 2.86 | -3.38 % | $ 92.8 K |  USA |
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.99 B | $ 118.89 | 0.64 % | $ 36.1 B | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 13.75 | -3.17 % | $ 416 M | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 107.73 | -0.5 % | $ 8.89 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.3 B | $ 636.84 | 0.02 % | $ 51.2 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 130.15 | -2.06 % | $ 20.7 B | USA |
 |
Celcuity
CELC
|
113 M | $ 108.05 | -0.24 % | $ 4.26 B | USA |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 27.48 | -1.84 % | $ 763 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 283.25 | -1.05 % | $ 23.6 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 79.36 | 4.01 % | $ 5.36 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
607 M | $ 175.2 | -1.93 % | $ 8.68 B | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 318.91 | -0.31 % | $ 27.2 B |  Schweiz |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
964 M | $ 5.21 | 3.89 % | $ 482 M | USA |
 |
NeoGenomics
NEO
|
430 M | $ 9.59 | 0.89 % | $ 1.23 B | USA |
 |
Natera
NTRA
|
258 M | $ 208.22 | 4.02 % | $ 20.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
Pacific Biosciences of California
PACB
|
600 M | $ 1.52 | -6.17 % | $ 456 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Precipio
PRPO
|
13.6 M | $ 24.7 | 0.08 % | $ 32.1 M | USA |
|
Biodesix
BDSX
|
106 M | $ 15.67 | -0.51 % | $ 2.03 B | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Senseonics Holdings
SENS
|
61.8 M | $ 6.82 | -17.66 % | $ 285 M | USA |
 |
Sotera Health Company
SHC
|
309 M | $ 15.74 | -1.06 % | $ 4.47 B | USA |
 |
Soleno Therapeutics
SLNO
|
181 M | $ 38.17 | -2.28 % | $ 1.94 B | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.12 | -2.19 % | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 208.58 | -0.79 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 204.29 | -0.83 % | $ 146 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | $ 103.36 | - | $ 19.5 B | USA |
 |
Bioventus
BVS
|
217 M | $ 8.78 | 0.11 % | $ 550 M | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.3 | -4.19 % | $ 292 M |  Israel |
 |
DexCom
DXCM
|
1.89 B | $ 72.86 | -1.24 % | $ 28.4 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.15 B | $ 507.94 | -0.1 % | $ 191 B | USA |
 |
Twist Bioscience Corporation
TWST
|
116 M | $ 47.14 | 2.72 % | $ 2.82 B | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 24.01 | -6.38 % | $ 254 M | China |
 |
VolitionRx Limited
VNRX
|
28.3 M | $ 0.2 | -2.22 % | $ 19.2 M |  Singapore |
 |
CareDx, Inc
CDNA
|
411 M | $ 18.74 | -0.03 % | $ 999 M | USA |
 |
Waters Corporation
WAT
|
687 M | $ 311.27 | 1.35 % | $ 18.5 B | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
226 M | $ 94.75 | 2.73 % | $ 11.9 B | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 173.82 | -0.27 % | $ 29.9 B | USA |